Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib in relapsed/refractory multiple myeloma
NCT02499081Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Sep 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM), sponsored by University of Arkansas. Started Sep 2015; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02499081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499081.